Hrt Financial LP Pa Vmed Inc. Transaction History

Hrt Financial LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.57 - $34.65 $8,550 - $519,750	15,000 New	15,000 $12,000
Q4 2021 Feb 14, 2022	SELL	$2.46 - $8.74 $211,638 - $751,919	-86,032 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.1 - $9.39 $438,763 - $807,840	86,032 New	86,032 $734,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.